๐ฐ Groupa Streptococcus News
Page 5 - Groupa Streptococcus News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Groupa Streptococcus. Real-time updates on events, politics, business and more.
February 8, 2024
Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have earned a consensus rating of “Buy” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have covered the stock in the last […]
February 8, 2024
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) SVP Mikhail Eydelman sold 1,667 shares of the company’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $73.87, for a total transaction of $123,141.29. Following the completion of the transaction, the senior vice president now owns 20,710 shares of […]
February 6, 2024
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) SVP Mikhail Eydelman sold 1,667 shares of the company’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $73.87, for a total transaction of $123,141.29. Following the transaction, the senior vice president now owns 20,710 shares in the company, valued […]
February 4, 2024
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) Director Heath Lukatch sold 5,000 shares of the company’s stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $71.50, for a total transaction of $357,500.00. Following the completion of the sale, the director now directly owns 5,625 shares in the […]
February 2, 2024
Canada is seeing a record number of cases of invasive group A strep, a bacterial infection that kills roughly one in 10 people who contract it. Hereโs everything you need to know including common symptoms, treatment, and whoโs most at risk.
February 2, 2024
Victory Capital Management Inc. cut its holdings in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 6.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 430,949 shares of the company’s stock after selling 31,355 shares during the quarter. Victory Capital Management […]
January 31, 2024
Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) gapped up before the market opened on Wednesday . The stock had previously closed at $67.35, but opened at $70.60. Vaxcyte shares last traded at $69.57, with a volume of 403,300 shares trading hands. Wall Street Analyst Weigh In Several brokerages have recently weighed in on […]
January 29, 2024
Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) reached a new 52-week high during trading on Monday . The company traded as high as $66.48 and last traded at $66.41, with a volume of 180384 shares traded. The stock had previously closed at $64.31. Analyst Ratings Changes A number of analysts recently commented on […]
January 29, 2024
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report)’s share price hit a new 52-week high on Monday . The company traded as high as $66.48 and last traded at $66.41, with a volume of 180384 shares trading hands. The stock had previously closed at $64.31. Analyst Upgrades and Downgrades A number of brokerages recently weighed in […]
January 28, 2024
Kim Wetmore is urging people to go to the hospital or get a test if you've got symptoms of strep A. She doesn't want people to have to go through the same pain she is going through now.Her husband, Dan Wetmore, died of strep A in Moncton, N.B., on Jan. 19 at the age of 49. He had been sick for more than a week."By him putting it off and putting it off and putting it off, it ended his life," said Wetmore. Canada is seeing a record number of cases of invasive Group A strep, a b...